Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml, Fertigspritzen

7680627190013 CH-62719 Fertigspritzen
Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml, Fertigspritzen
Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml, Fertigspritzen
Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml, Fertigspritzen
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Fertigspritzen
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
29/12/2021
Summary of Product Characteristics
Français
29/12/2021
Summary of Product Characteristics
Italien
29/12/2021

Detailed composition

Substance Quantity Type Category
(N/A)
3.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
12.53 MG Substance HBESI

Reimbursement information

Public price
CHF 62.55
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/03/2014

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
62719
Drug name
Ibandronat-Mepha Osteo i.v., Fertigspritzen
Galenic form
LSPA
ATC Code
M05BA06
Authorization status
Z
Dispensing category
B
First authorization
20/11/2013
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Package details

Description (FR)
IBANDRONAT Mepha Osteo 3 mg/3ml i.v. ser prê 3 ml
Description (DE)
IBANDRONAT Mepha Osteo 3 mg/3ml i.v. Fertspr 3 ml
Market launch
20/11/2013
Narcotic (BTM)
No

Original drug

Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680574240014
CHF 210.75
View original